Science teaches us to always ask questions.
An answer should never be accepted unless there is abundant evidence to prove its veracity.
This very principle has guided the scientific process through generations of research. It was this principle that caused me to rethink and ultimately repudiate my nearly two decades in animal research.
I started doing animal research, like so many of my colleagues, with the presumption that my research was somehow going to save lives.
I was uncomfortable with using animals to simulate human conditions, but I believed the benefits outweighed the harm that I was causing to the animals. I believed that as a veterinarian, I would be best able to understand the animal condition and provide the best care possible.
There were many proud moments in those years. I had a tremendous sense of accomplishment after successfully defending my dissertation.
Whenever I worked with the many engineers and surgeons, as they developed artificial organs, I felt as if I were on the very edge of medical advancement.
The first time I saw someone who was alive thanks to an artificial heart that I had helped test still remains one of best moments in my career.
In the beginning, there was a scientific question: How could the animal model be improved to better simulate the human condition?
Again, I believed that as a veterinarian, I would best be able to understand how to create a disease in the animal that would sufficiently mimic the human disease, without unduly harming the animal.
I carefully monitored and treated the animals to minimize any pain. I did what I could to improve their conditions.
In retrospect, I was fooling myself. The similarities between a human disease and an artificially manufactured animal disease are akin to a plastic lawn flamingo and the real bird; they are both pink, but any closer examination reveals how truly different they are.
Then came the realization that no amount of improvement and no amount of transformation could ever make an animal disease model be anything but the palest reflection of the human condition.
It was at that moment that I was able to step back and understand how animal research has misinformed medicine. By focusing on disease models that look similar, but are very different, science has forgotten to ask the questions.
Those questions necessarily make us uncomfortable. Any time we are forced to consider that our assumptions are wrong, it is difficult.
Animal research is built on a pyramid of assumptions. It is assumed that if humans and animals have the same gene, it has the same triggers and same actions.
It is assumed that artificially created heart failure in a dog will inform our ability to manage heart failure in people.
It is assumed that when a rat becomes diabetic after being fed a high-fat, high-cholesterol diet, it can be used to improve our ability to treat the condition in people.
At first glance, all of those seem reasonable.
Each describes an animal model that is being used to test new human therapies.
Each of those models, and every other artificially constructed animal model of human disease, are built upon so many assumptions that the end results only serve to mislead medical therapy.
If heart disease in humans develops over decades, why is it assumed that we will learn how to treat the condition based upon results of a dog that was normal one day and in heart failure the next?
If the therapies we use for Alzheimer’s disease are based upon the results of animal research, where drugs are injected into the animals to produce similar symptoms to the human condition, what exactly are we learning how to treat?
Does it make sense that our approach to diabetes is based upon animals that are inbred, have had multiple gene manipulations and are fed toxic levels of cholesterol and fat?
The answers to those questions and any others, related to the current use of animals in research, lead to the same conclusion.
Animal research is based upon so many flawed premises that it has only served to mislead and misinform medical progress.
The pyramid of assumptions in animal research does not have a solid base in scientific fact; rather it has been built on a Ponzi scheme of ever-increasing conjecture and chance.
Human beings have near-infinite creativity in solving problems. We should not be wasting it on the stifling approach to medical breakthroughs that animal research presents us.
Kenneth Litwak is a former laboratory animal veterinarian. He is currently on the staff of the US nonprofit Physicians Committee for Responsible Medicine, based in Washington.
US President Donald Trump has gotten off to a head-spinning start in his foreign policy. He has pressured Denmark to cede Greenland to the United States, threatened to take over the Panama Canal, urged Canada to become the 51st US state, unilaterally renamed the Gulf of Mexico to “the Gulf of America” and announced plans for the United States to annex and administer Gaza. He has imposed and then suspended 25 percent tariffs on Canada and Mexico for their roles in the flow of fentanyl into the United States, while at the same time increasing tariffs on China by 10
Trying to force a partnership between Taiwan Semiconductor Manufacturing Co (TSMC) and Intel Corp would be a wildly complex ordeal. Already, the reported request from the Trump administration for TSMC to take a controlling stake in Intel’s US factories is facing valid questions about feasibility from all sides. Washington would likely not support a foreign company operating Intel’s domestic factories, Reuters reported — just look at how that is going over in the steel sector. Meanwhile, many in Taiwan are concerned about the company being forced to transfer its bleeding-edge tech capabilities and give up its strategic advantage. This is especially
US President Donald Trump last week announced plans to impose reciprocal tariffs on eight countries. As Taiwan, a key hub for semiconductor manufacturing, is among them, the policy would significantly affect the country. In response, Minister of Economic Affairs J.W. Kuo (郭智輝) dispatched two officials to the US for negotiations, and Taiwan Semiconductor Manufacturing Co’s (TSMC) board of directors convened its first-ever meeting in the US. Those developments highlight how the US’ unstable trade policies are posing a growing threat to Taiwan. Can the US truly gain an advantage in chip manufacturing by reversing trade liberalization? Is it realistic to
Last week, 24 Republican representatives in the US Congress proposed a resolution calling for US President Donald Trump’s administration to abandon the US’ “one China” policy, calling it outdated, counterproductive and not reflective of reality, and to restore official diplomatic relations with Taiwan, enter bilateral free-trade agreement negotiations and support its entry into international organizations. That is an exciting and inspiring development. To help the US government and other nations further understand that Taiwan is not a part of China, that those “one China” policies are contrary to the fact that the two countries across the Taiwan Strait are independent and
RSS